Investors & Media

SEC Filings

Document Details

Form
Filing Date
January 18, 2024
Document Date
January 16, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Pierce Valerie L

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com